Clemson Bioengineering

Dr. Will Richardson: An R01 to Predict and Prevent Cardiac Fibrosis

Paul Alongi The millions of patients who suffer from a condition that contributes to heart failure could receive personalized risk assessments and treatments with the help of new research led by Dr. Will Richardson of Clemson University. Richardson, an assistant professor of bioengineering, is receiving an R01 grant of $1.9 million from the National Institutes […]

Diabetes Targeted in New Bioengineering Research at Clemson University

By Paul Alongi Clemson University bioengineers are launching a new research project to better understand cardiovascular disease in patients with diabetes, an affliction that affects about 13 percent of South Carolina adults and cost $4.3 billion last year alone. What the bioengineers learn could help lay the groundwork for future studies aimed at finding new […]

New treatment for spinal cord injuries could help patients walk again

Paul Alongi     Lee said patients who have suffered from spinal cord injuries have inspired her research, , particularly their courage and optimism.  “I believe the nanotherapeutics we are developing can provide a platform for drug therapies that can mitigate injury damage and lay the groundwork for regeneration, Lee said. “I want to see […]